Corbus Pharmaceuticals Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Corporate Updates

/PRNewswire/ -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), an immunology company, today provided corporate updates and...

Related Keywords

Massachusetts ,United States ,Jenene Thomas ,Yuval Cohen ,Exchange Commission ,National Institutes Of Phase ,Securities Exchange ,Prnewswire Corbus Pharmaceuticals Holdings Inc ,Corbus Pharmaceuticals Holdings Inc ,Nasdaq ,Program Updates ,Pharmaceuticals Holdings ,Rachael Brake ,Chief Scientific Officer ,National Institutes ,Health Sponsored Phase ,Chief Executive Officer ,Fourth Quarter ,Year End December ,Securities Act ,Securities Exchange Act ,Private Securities Litigation Reform Act ,Consolidated Statements ,Three Months ,Years Ended ,Corbus Pharmaceuticals Holdings ,Nc ,